TCR sequencing: applications in immuno-oncology research
Immuno-Oncology and Technology · 2023-03 · 17 · 100373
DOI: 10.1016/j.iotech.2023.100373 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immuno-Oncology and Technology, 2023-03. Verfasst von Á F Sanromán und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Royal Marsden Cancer Charity, Medical Research Council.
Abstract (Originalsprache)
•T-cell receptor (TCR) interaction with major histocompatibility complex-antigen complexes leads to antitumour responses.•TCR sequencing analysis allows characterisation of T cells that recognise tumour neoantigens.•T-cell clonal revival and clonal replacement potentially underpin immunotherapy responses.
Autor:innen und Institutionen
- Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
- Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK.
- Renal and Skin Unit, The Royal Marsden NHS Foundation Trust, London, UK.
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
- Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia.
Förderung
- Cancer Research UK
- Royal Marsden Cancer Charity
- Medical Research Council
- National Institutes of Health
- National Institute for Health and Care Research
- Melanoma Research Alliance
- Wellcome Trust
- Institute of Cancer Research
Zitieren
APA
Sanromán, Á. F., Joshi, K., Au, L., Chain, B., & Turajlic, S. (2023). TCR sequencing: applications in immuno-oncology research. Immuno-Oncology and Technology, 17, 100373. https://doi.org/10.1016/j.iotech.2023.100373
Vancouver
Sanromán ÁF, Joshi K, Au L, Chain B, Turajlic S. TCR sequencing: applications in immuno-oncology research. Immuno-Oncology and Technology. 2023;17:100373. doi:10.1016/j.iotech.2023.100373
BibTeX
@article{Sanromn2023,
author = {Sanromán, Á F and Joshi, K and Au, L and Chain, B and Turajlic, S},
title = {TCR sequencing: applications in immuno-oncology research},
journal = {Immuno-Oncology and Technology},
year = {2023},
volume = {17},
pages = {100373},
doi = {10.1016/j.iotech.2023.100373}
}
EUVIMED